GeneDx Holdings WGS GeneDx — Adjusted cost of services

Similar metrics at other companies

BIOClinical Diagnostics — Cost of goods sold

$181.8M+1.5%

AVT

AVTRBioscience & Medtech Products — Adjusted cost of goods and services sold

$226.7M+5.2%

GEHCPDx — Total Costs & Expenses

$573M+33.9%

TMOSpecialty Diagnostics — Cost of revenues

$657M-3.2%

OPKDiagnostics — Cost of Goods Sold

$56.14M-33.6%

NEOGGenomics Services — Revenue

$22.8M+0.4%

Questions, answered.

What is GeneDx Holdings's genedx — adjusted cost of services?

GeneDx Holdings (WGS) reported genedx — adjusted cost of services of $31.61M in Q1 2026.

How has GeneDx Holdings's genedx — adjusted cost of services changed year-over-year?

GeneDx Holdings's genedx — adjusted cost of services increased by 15.4% year-over-year, from $27.4M to $31.61M.

What is the long-term trend for GeneDx Holdings's genedx — adjusted cost of services?

Over 2 years (2023 to 2025), GeneDx Holdings's genedx — adjusted cost of services has grown at a 6.8% compound annual growth rate (CAGR), from $106.98M to $122.1M.

What does genedx — adjusted cost of services mean?

Reflects the direct costs incurred by the GeneDx segment to deliver its diagnostic services, excluding certain non-recurring or non-cash items. This metric is used to evaluate the efficiency of the core operational delivery process.